[HTML][HTML] Increasing diversity in clinical trials: overcoming critical barriers
…, B Jamerson, C McCullough, C Pierre, AB Polis… - Current problems in …, 2019 - Elsevier
Clinical trial results provide the critical evidence base for evaluating the safety and efficacy
of new medicines and medical products. Efficacy and safety may differ among population …
of new medicines and medical products. Efficacy and safety may differ among population …
Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial
GP Geba, AL Weaver, AB Polis, ME Dixon, TJ Schnitzer… - Jama, 2002 - jamanetwork.com
ContextOsteoarthritis (OA) is often treated with nonsteroidal anti-inflammatory drugs (NSAIDs),
acetaminophen, or specific inhibitors of cyclooxygenase 2 (COX-2).ObjectiveTo assess …
acetaminophen, or specific inhibitors of cyclooxygenase 2 (COX-2).ObjectiveTo assess …
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension …
…, D Gurner, DL Miller, ML Blair, AB Polis… - The lancet Diabetes & …, 2019 - thelancet.com
Background Odanacatib, a cathepsin K inhibitor, reduces bone resorption while maintaining
bone formation. Previous work has shown that odanacatib increases bone mineral density …
bone formation. Previous work has shown that odanacatib increases bone mineral density …
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression
…, WL Luo, AA MacLean, LB Peterson, AB Polis… - Science translational …, 2012 - science.org
Nicotinic acid (niacin) induces beneficial changes in serum lipoproteins and has been
associated with beneficial cardiovascular effects. Niacin reduces low-density lipoprotein, …
associated with beneficial cardiovascular effects. Niacin reduces low-density lipoprotein, …
Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial
…, CS Skalky, ME Dixon, AB Polis… - Annals of internal …, 2003 - acpjournals.org
… In their recent letter to the editor, Braunstein and Polis address … The 2003 article by Lisse
and colleagues (including Polis) … In their Annals letter, Braunstein and Polis say that Merck's …
and colleagues (including Polis) … In their Annals letter, Braunstein and Polis say that Merck's …
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial
…, DG Armstrong, AD Tice, AB Polis… - International wound …, 2007 - Wiley Online Library
To aid clinicians in selecting the appropriate approach for treating patients with diabetic foot
infections, we investigated whether any baseline clinical findings predicted an unfavourable …
infections, we investigated whether any baseline clinical findings predicted an unfavourable …
Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP* trial
DG Armstrong, BA Lipsky, AB Polis… - International wound …, 2006 - Wiley Online Library
The purpose of the study was to assess in patients with a diabetic foot infection (DFI), whether
differences in skin temperature of the affected foot as compared to the corresponding site …
differences in skin temperature of the affected foot as compared to the corresponding site …
Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis
BM Ambegaonkar, D Tipping, AB Polis, JE Tomassini… - Atherosclerosis, 2014 - Elsevier
Objective: Evaluate the lipid-altering effects of ezetimibe added to ongoing statin therapy,
statin titration, switching from statin monotherapy to a more potent statin or to ezetimibe/…
statin titration, switching from statin monotherapy to a more potent statin or to ezetimibe/…
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET …
…, HH Parving, JB Rosen, AJ Adewale, AB Polis… - The American journal of …, 2009 - Elsevier
Patients with the metabolic syndrome are at an increased risk of cardiovascular disease
and might require intensive lipid therapy. Many patients remain at the starting dose of lipid …
and might require intensive lipid therapy. Many patients remain at the starting dose of lipid …
The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial
BA Lipsky, AB Polis, KC Lantz… - Wound Repair and …, 2009 - Wiley Online Library
Scoring the severity of a diabetic foot wound infection may help assess the severity, determine
the type and urgency of antibiotic and surgical treatment needed, and predict clinical …
the type and urgency of antibiotic and surgical treatment needed, and predict clinical …